Al Musaimi O

ORCID: 0000-0003-2421-1825 · 2 papers in corpus
review 2025
International journal of molecular sciences ·doi:10.3390/ijms26146815

Cancer remains a leading global health burden, profoundly affecting patient survival and quality of life. Current treatments-including chemotherapy, radiotherapy, immunotherapy, and surgery-are often limited by toxicity or insufficient spec…

review 2024
Cancers ·doi:10.3390/cancers16051032

The United States Food and Drug Administration (FDA) has approved a plethora of peptide-based drugs as effective drugs in cancer therapy. Peptides possess high specificity, permeability, target engagement, and a tolerable safety profile. Th…